Insufficienza renale cronica in un paziente coinfetto HIV/HCV tossicodipendente. Un iter diagnosticoterapeutico complesso.: “… Lasciate ogne speranza,voi ch'intrate” ?
Restricted accessResearch articleFirst published online January, 2008
Insufficienza renale cronica in un paziente coinfetto HIV/HCV tossicodipendente. Un iter diagnosticoterapeutico complesso.: “… Lasciate ogne speranza,voi ch'intrate” ?
WyattC.M., KlotmanP.E.HIV-1 and HIV-associated nephropathy 25 years later. Clin J Am Soc Nephrol2007; 2(suppl 1): S20–4. Review.
2.
De SilvaT.I., PostF.A., GriffinM.D., DockrellD.H.HIV-1 infection and the kidney: an evolving challenge in HIV medicine. Mayo Clin Proc2007; 82(9): 1103–16. Review.
3.
IzzedineH., DerayG.The nephrologist in the HAART era. AIDS2007, 21: 409–21.
4.
KhannaR., TachopoulouO.A., FeinP.A., ChattopadhyayJ., AvramM.M.Survival experience of peritoneal dialysis patients with human immunodeficiency virus: a 17-year retrospective study. Adv Perit Dial2005; 21: 159–63.
5.
AhujaT.S., CollingeN., GradyJ., KhanS.Is dialysis modality a factor in survival of patients with ESRD and HIV-associated nephropathy?Am J Kidney Dis2003; 41: 1060–4.
6.
RodriguezR.A., MendelsonM., O'HareA.M., HsuL.C., SchoenfeldP.Determinants of survival among HIV-infected chronic dialysis patients. J Am Soc Nephrol2003; 14(5): 1307–13.
7.
TourretJ., TostivintI., du MontcelS.T.Outcome and prognosis factors in HIV-infected hemodialysis patients. Clin J Am Soc Nephrol2006; 1(6): 1241–7.
8.
SorianoV., PuotiM., SulkowskiM.Care of patients coinfected with HIV and Hepatitis C virus. 2007 updated recommendations from the HCV-HIV International Panel. AIDS2007; 21: 1073–89.
RendinaM., SchenaA., CastellanetaN.M.The treatment of chronic hepatitis C with peginterferon alfa-2a (40 kDa) plus ribavirin in haemodialysed patients awaiting renal transplant. J Hepatol2007; 46(5): 768–74.
11.
FabriziF., LunghiG., GaneshanS.V., MartinP., MessaP.Hepatitis C virus infection and the dialysis patient. Semin Dial2007; 20(5): 416–22. Review.
12.
BruchfeldA., LindahlK., SchvrczR., StåhleL.Dosage of ribavirin in patients with hepatitis C should be based on renal function: a population pharmacokinetic analysis. Ther Drug Monit2002; 24: 701–8.
